Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project

The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer...

Full description

Saved in:
Bibliographic Details
Published inBreast cancer research and treatment Vol. 131; no. 2; pp. 637 - 643
Main Authors Beasley, Jeannette M., Kwan, Marilyn L., Chen, Wendy Y., Weltzien, Erin K., Kroenke, Candyce H., Lu, Wei, Nechuta, Sarah J., Cadmus-Bertram, Lisa, Patterson, Ruth E., Sternfeld, Barbara, Shu, Xiao-Ou, Pierce, John P., Caan, Bette J.
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.01.2012
Springer
Springer Nature B.V
Subjects
Online AccessGet full text
ISSN0167-6806
1573-7217
1573-7217
DOI10.1007/s10549-011-1770-1

Cover

Abstract The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18–32 months) were pooled in the After Breast Cancer Pooling Project ( n  = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality ( n  = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66–0.82) and a 25% reduction in breast cancer mortality ( n  = 971 events, HR = 0.75, 95% CI 0.65–0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence ( n  = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86–1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.
AbstractList The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 hours (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18 to 32 months) were pooled in the After Breast Cancer Pooling Project (n=13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n=1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66–0.82) and a 25% reduction in breast cancer mortality (n=971 events, HR=0.75, 95% CI 0.65–0.85) compared to women who did not meet the PA Guidelines (< 10 MET-hours/week). Risk of breast cancer recurrence (n=1,421 events) was not associated with meeting the PA Guidelines (HR=0.96, 95% CI, 0.86–1.06). These data suggest that adhering to the PA Guidelines may be an important intervention target for reducing mortality among breast cancer survivors.
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors. Keywords Physical activity guidelines * Breast cancer survival * Mortality * Epidemiology
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18-32 months) were pooled in the After Breast Cancer Pooling Project (n = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality (n = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66-0.82) and a 25% reduction in breast cancer mortality (n = 971 events, HR = 0.75, 95% CI 0.65-0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence (n = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86-1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.[PUBLICATION ABSTRACT]
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to reduce risk of morbidity and mortality. This analysis was conducted to investigate whether this recommendation can be extended to breast cancer survivors. Data from four studies of breast cancer survivors measuring recreational PA from semi-quantitative questionnaires a median of 23 months post-diagnosis (interquartile range 18–32 months) were pooled in the After Breast Cancer Pooling Project ( n  = 13,302). Delayed entry Cox proportional hazards models were applied in data analysis with adjustment for age, post-diagnosis body mass index, race/ethnicity, menopausal status, TNM stage, cancer treatment, and smoking history. Engaging in at least 10 MET-hours/week of PA was associated with a 27% reduction in all-cause mortality ( n  = 1,468 events, Hazard Ratio (HR) = 0.73, 95% CI, 0.66–0.82) and a 25% reduction in breast cancer mortality ( n  = 971 events, HR = 0.75, 95% CI 0.65–0.85) compared with women who did not meet the PA Guidelines (<10 MET-hours/week). Risk of breast cancer recurrence ( n  = 1,421 events) was not associated with meeting the PA Guidelines (HR = 0.96, 95% CI, 0.86–1.06). These data suggest that adhering to the PA guidelines may be an important intervention target for reducing mortality among breast cancer survivors.
Audience Academic
Author Lu, Wei
Weltzien, Erin K.
Kroenke, Candyce H.
Cadmus-Bertram, Lisa
Beasley, Jeannette M.
Patterson, Ruth E.
Shu, Xiao-Ou
Kwan, Marilyn L.
Nechuta, Sarah J.
Caan, Bette J.
Chen, Wendy Y.
Pierce, John P.
Sternfeld, Barbara
AuthorAffiliation 4 Shanghai Center for Disease Control and Prevention, Shanghai, China
2 Kaiser Permanente Division of Research, Oakland, CA 94612
5 Vanderbilt University, Nashville, TN 37203
3 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
6 Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, San Diego, CA 92093
1 Fred Hutchinson Cancer Research Center, Seattle, WA 98109
AuthorAffiliation_xml – name: 3 Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
– name: 2 Kaiser Permanente Division of Research, Oakland, CA 94612
– name: 5 Vanderbilt University, Nashville, TN 37203
– name: 6 Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California, San Diego, San Diego, CA 92093
– name: 4 Shanghai Center for Disease Control and Prevention, Shanghai, China
– name: 1 Fred Hutchinson Cancer Research Center, Seattle, WA 98109
Author_xml – sequence: 1
  givenname: Jeannette M.
  surname: Beasley
  fullname: Beasley, Jeannette M.
  email: jbeasley@whi.org
  organization: Fred Hutchinson Cancer Research Center
– sequence: 2
  givenname: Marilyn L.
  surname: Kwan
  fullname: Kwan, Marilyn L.
  organization: Kaiser Permanente Division of Research
– sequence: 3
  givenname: Wendy Y.
  surname: Chen
  fullname: Chen, Wendy Y.
  organization: Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School
– sequence: 4
  givenname: Erin K.
  surname: Weltzien
  fullname: Weltzien, Erin K.
  organization: Kaiser Permanente Division of Research
– sequence: 5
  givenname: Candyce H.
  surname: Kroenke
  fullname: Kroenke, Candyce H.
  organization: Kaiser Permanente Division of Research
– sequence: 6
  givenname: Wei
  surname: Lu
  fullname: Lu, Wei
  organization: Shanghai Center for Disease Control and Prevention
– sequence: 7
  givenname: Sarah J.
  surname: Nechuta
  fullname: Nechuta, Sarah J.
  organization: Vanderbilt University
– sequence: 8
  givenname: Lisa
  surname: Cadmus-Bertram
  fullname: Cadmus-Bertram, Lisa
  organization: Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California
– sequence: 9
  givenname: Ruth E.
  surname: Patterson
  fullname: Patterson, Ruth E.
  organization: Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California
– sequence: 10
  givenname: Barbara
  surname: Sternfeld
  fullname: Sternfeld, Barbara
  organization: Kaiser Permanente Division of Research
– sequence: 11
  givenname: Xiao-Ou
  surname: Shu
  fullname: Shu, Xiao-Ou
  organization: Vanderbilt University
– sequence: 12
  givenname: John P.
  surname: Pierce
  fullname: Pierce, John P.
  organization: Cancer Prevention and Control Program, Moores UCSD Cancer Center, University of California
– sequence: 13
  givenname: Bette J.
  surname: Caan
  fullname: Caan, Bette J.
  organization: Kaiser Permanente Division of Research
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25422632$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21935600$$D View this record in MEDLINE/PubMed
BookMark eNp9kk9vEzEQxS1URNPAB-CCVqACly22d72OOSBVFf-kIi5wtrzeceJoY6e2N1JufPR6SWibqlQ-rGT_3pvZmXeCjpx3gNBLgs8IxvxDJJjVosSElIRzXJInaEIYr0pOCT9CE0waXjYz3ByjkxiXGGPBsXiGjikRFWswnqA_PwCSdfMiLaBYL7bRatUXSie7sWlbzAfbQW8dxEK5rohD2NjNCJgEoWgDqJgKrZyG8LEw1nXZKhYm-NVfwwewYu19PxZcB78EnZ6jp0b1EV7sv1P0-8vnXxffysufX79fnF-WumE0lUZgAppThnXV1s2s5czwulVGC0aIEqqFGgvDhOoaXc2aiqq2VRgDbnjLKa2m6NPOdz20K-g0uBRUL9fBrlTYSq-sPHxxdiHnfiMrymnVjAbv9gbBXw0Qk1zZqKHvlQM_RClIletQITL5_lGS1GzGKOe5yyl6fQ9d-iG4PIjRryKCMZyhNztornqQ1hmfG9SjpzzPa2QzgpuROnuAyqeDldU5OMbm-wPB2zuCBag-LaLvh2S9i4fgq7uju5nZvxRl4HQPqJjjY0LetI23HKspzRvJHNlxOvgYA5gbhGA5JlruEi1zouWYaEmyht_TaJvU2GP-Pds_qqQ7ZcxV3BzC7Wz_L7oGkZAI4g
CODEN BCTRD6
CitedBy_id crossref_primary_10_1186_s12885_015_1971_9
crossref_primary_10_1007_s10549_012_2274_3
crossref_primary_10_1007_s10549_016_3970_1
crossref_primary_10_1177_15347354221140327
crossref_primary_10_3390_ijms24054974
crossref_primary_10_1097_SGA_0000000000000252
crossref_primary_10_1158_1078_0432_CCR_16_0067
crossref_primary_10_1002_ijc_28130
crossref_primary_10_3390_ijerph110505487
crossref_primary_10_3390_ijerph20064872
crossref_primary_10_1136_bmjopen_2022_062288
crossref_primary_10_1093_jnci_djaa046
crossref_primary_10_1136_bmjopen_2023_076321
crossref_primary_10_3389_fonc_2020_563566
crossref_primary_10_1007_s13668_011_0004_9
crossref_primary_10_1007_s00520_013_2065_3
crossref_primary_10_1158_0008_5472_CAN_15_3307
crossref_primary_10_3390_cancers11010062
crossref_primary_10_1007_s10654_014_9916_1
crossref_primary_10_1360_SSV_2022_0235
crossref_primary_10_1007_s11764_015_0441_3
crossref_primary_10_3109_0284186X_2014_998275
crossref_primary_10_1200_JCO_23_01959
crossref_primary_10_1016_j_breast_2021_05_004
crossref_primary_10_1007_s40615_022_01405_4
crossref_primary_10_1136_bmjopen_2018_026797
crossref_primary_10_1016_j_ypmed_2017_05_029
crossref_primary_10_1249_MSS_0000000000002539
crossref_primary_10_1007_s00520_021_06706_8
crossref_primary_10_1016_j_cct_2020_106001
crossref_primary_10_1136_bmjopen_2019_032871
crossref_primary_10_1016_j_cct_2021_106524
crossref_primary_10_1093_annonc_mdu012
crossref_primary_10_1123_jpah_2019_0037
crossref_primary_10_1038_s41568_019_0145_5
crossref_primary_10_1097_PPO_0000000000000405
crossref_primary_10_1158_1055_9965_EPI_22_1274
crossref_primary_10_1016_j_critrevonc_2014_12_012
crossref_primary_10_1007_s11764_021_01104_9
crossref_primary_10_1080_14635240_2021_2004438
crossref_primary_10_4048_jbc_2022_25_e42
crossref_primary_10_1007_s10552_013_0252_7
crossref_primary_10_1089_acm_2014_0061
crossref_primary_10_1089_act_2015_29006_cr
crossref_primary_10_1016_j_ygyno_2018_01_020
crossref_primary_10_3389_fonc_2024_1393902
crossref_primary_10_1007_s11845_021_02785_y
crossref_primary_10_1017_S0029665118000010
crossref_primary_10_1007_s10269_015_2582_4
crossref_primary_10_1093_jncimonographs_lgad011
crossref_primary_10_3390_ijerph20065197
crossref_primary_10_3390_cancers13215329
crossref_primary_10_1002_ijc_34324
crossref_primary_10_1002_14651858_CD011292
crossref_primary_10_1097_NCC_0000000000000580
crossref_primary_10_1016_j_revmed_2015_12_021
crossref_primary_10_1177_1534735417731514
crossref_primary_10_1177_1534735420943269
crossref_primary_10_1007_s12609_014_0147_y
crossref_primary_10_3109_09593985_2015_1004390
crossref_primary_10_1007_s10552_016_0726_5
crossref_primary_10_1186_s12885_016_2244_y
crossref_primary_10_1186_s40064_015_0912_z
crossref_primary_10_1016_j_bulcan_2020_07_003
crossref_primary_10_1111_ajco_13834
crossref_primary_10_1002_cncr_30440
crossref_primary_10_15430_JCP_2013_18_3_193
crossref_primary_10_2217_fon_2017_0037
crossref_primary_10_1007_s10903_018_0721_x
crossref_primary_10_1007_s11764_020_00856_0
crossref_primary_10_1002_ijc_29940
crossref_primary_10_1093_jncics_pkz080
crossref_primary_10_1002_14651858_CD011292_pub2
crossref_primary_10_1007_s10549_014_3216_z
crossref_primary_10_1007_s10552_014_0431_1
crossref_primary_10_1007_s00520_014_2346_5
crossref_primary_10_1007_s10552_022_01663_x
crossref_primary_10_3390_cancers14071756
crossref_primary_10_1002_cncr_28630
crossref_primary_10_1586_erp_12_37
crossref_primary_10_1016_j_pranut_2021_06_005
crossref_primary_10_1007_s10552_013_0294_x
crossref_primary_10_1016_j_ijnurstu_2018_12_002
crossref_primary_10_1007_s12094_020_02388_6
crossref_primary_10_1016_j_canep_2015_03_009
crossref_primary_10_1097_EDE_0000000000000933
crossref_primary_10_1188_20_ONF_703_719
crossref_primary_10_1002_ijc_28740
crossref_primary_10_1097_EDE_0000000000000373
crossref_primary_10_31083_j_rcm2406160
crossref_primary_10_17650_1994_4098_2022_18_3_40_51
crossref_primary_10_1007_s11764_013_0265_y
crossref_primary_10_1093_jnci_djs473
crossref_primary_10_1016_j_puhe_2016_03_028
crossref_primary_10_1016_j_ejca_2016_10_025
crossref_primary_10_1093_epirev_mxx007
crossref_primary_10_1186_1471_2407_13_153
crossref_primary_10_1016_j_breast_2019_02_001
crossref_primary_10_1016_j_ejca_2016_07_010
crossref_primary_10_3322_caac_21405
crossref_primary_10_4048_jbc_2014_17_3_189
crossref_primary_10_1111_ecc_12617
crossref_primary_10_1001_jamanetworkopen_2021_3520
crossref_primary_10_3389_fpubh_2017_00019
crossref_primary_10_1016_j_bulcan_2020_06_013
crossref_primary_10_3390_cancers13236056
crossref_primary_10_1200_EDBK_432564
crossref_primary_10_1007_s00520_014_2185_4
crossref_primary_10_1007_s00520_020_05344_w
crossref_primary_10_1002_cncr_29786
crossref_primary_10_1007_s13668_013_0067_x
crossref_primary_10_1159_000356172
crossref_primary_10_1007_s13668_022_00431_2
crossref_primary_10_1111_ecc_13037
crossref_primary_10_3390_ijerph181910052
crossref_primary_10_1007_s00520_024_08831_6
crossref_primary_10_1249_MSS_0000000000001937
crossref_primary_10_1002_cam4_1847
crossref_primary_10_29328_journal_jsmt_1001034
crossref_primary_10_15829_1728_8800_2022_3235
crossref_primary_10_1007_s10269_015_2539_7
crossref_primary_10_1007_s12282_020_01211_y
crossref_primary_10_1007_s10269_016_2587_7
crossref_primary_10_1186_1748_5908_8_77
crossref_primary_10_3109_09593985_2015_1037409
crossref_primary_10_1159_000356044
crossref_primary_10_3390_nu15194245
crossref_primary_10_1007_s10549_014_2966_y
crossref_primary_10_1007_s12094_020_02312_y
crossref_primary_10_1017_S0029665118000447
Cites_doi 10.1007/s10552-010-9714-3
10.1093/ije/23.5.991
10.1158/1055-9965.EPI-08-0595
10.1093/aje/kwj127
10.1200/JCO.2006.08.6819
10.1007/s10552-011-9805-9
10.1016/S0197-2456(02)00241-6
10.1002/ijc.24155
10.1001/jama.293.20.2479
10.1001/jama.2009.1783
10.3138/physio.62.1.25
10.1016/0197-2456(86)90046-2
10.1097/00005768-200111000-00024
10.1249/00005768-199301000-00011
10.1200/JCO.2010.27.9752
10.1007/s10552-004-8340-3
10.1016/j.maturitas.2010.01.004
10.1158/1055-9965.EPI-07-0771
10.1038/nrc1608
10.1249/MSS.0b013e3181e0c112
10.1093/aje/kwg255
10.1158/1940-6207.CAPR-10-0295
10.5993/AJHB.31.2.8
10.1111/j.1753-4887.2008.00136.x
10.1158/1055-9965.1163.13.7
10.1007/s12032-010-9536-x
ContentType Journal Article
Copyright Springer Science+Business Media, LLC. 2011
2015 INIST-CNRS
COPYRIGHT 2012 Springer
Springer Science+Business Media, LLC. 2012
Copyright_xml – notice: Springer Science+Business Media, LLC. 2011
– notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2012 Springer
– notice: Springer Science+Business Media, LLC. 2012
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TO
7X7
7XB
88E
8AO
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
H94
K9-
K9.
M0R
M0S
M1P
M2O
MBDVC
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
Q9U
7TS
7X8
5PM
DOI 10.1007/s10549-011-1770-1
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
AIDS and Cancer Research Abstracts
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Consumer Health Database
ProQuest Health & Medical Collection
Medical Database
ProQuest Research Library
Research Library (Corporate)
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
Physical Education Index
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Research Library
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Central Basic
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
Physical Education Index
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
Physical Education Index


MEDLINE
Research Library Prep

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1573-7217
EndPage 643
ExternalDocumentID PMC3272362
2551526421
A356581060
21935600
25422632
10_1007_s10549_011_1770_1
Genre Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: 3R01CA118229-03S1
– fundername: NCI NIH HHS
  grantid: P01 CA087969
– fundername: NCI NIH HHS
  grantid: R01 CA118229
– fundername: NCI NIH HHS
  grantid: R01 CA129059
– fundername: NCI NIH HHS
  grantid: P01 CA87969
– fundername: National Cancer Institute : NCI
  grantid: R01 CA129059-04 || CA
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-XW
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
23N
28-
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
78A
7X7
88E
8AO
8C1
8FI
8FJ
8G5
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHVE
ACHXU
ACIHN
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACZOJ
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEAQA
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFDYV
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGVAE
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKNYI
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GUQSH
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IAO
ICW
IHE
IHR
IHW
IJ-
IKXTQ
IMOTQ
INH
INR
ITC
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
K9-
KDC
KOV
KOW
KPH
LAK
LLZTM
M0R
M1P
M2O
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RNI
ROL
RPX
RRX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UDS
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7W
Z81
Z82
Z83
Z87
Z8O
Z8Q
Z8U
Z8V
Z8W
Z91
ZGI
ZMTXR
ZOVNA
ZXP
~EX
~KM
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7TO
7XB
8FK
H94
K9.
MBDVC
PKEHL
PQEST
PQUKI
Q9U
7TS
PUEGO
7X8
5PM
ID FETCH-LOGICAL-c652t-f901ec7250c3b468b75f74bafc9511a9abe409f59ad6c38632abba00e067b7223
IEDL.DBID 8C1
ISSN 0167-6806
1573-7217
IngestDate Thu Aug 21 18:12:07 EDT 2025
Fri Sep 05 02:54:31 EDT 2025
Thu Sep 04 23:34:54 EDT 2025
Fri Aug 15 19:41:42 EDT 2025
Tue Jun 17 21:06:47 EDT 2025
Tue Jun 10 20:22:10 EDT 2025
Thu May 22 21:23:26 EDT 2025
Mon Jul 21 06:03:06 EDT 2025
Mon Jul 21 09:14:22 EDT 2025
Tue Jul 01 03:37:40 EDT 2025
Thu Apr 24 23:01:34 EDT 2025
Fri Feb 21 02:33:51 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Physical activity guidelines
Breast cancer survival
Epidemiology
Mortality
Physical exercise
Human
Breast disease
Breast cancer
Malignant tumor
Survival
Recommendation
Mammary gland diseases
Project
Public health
Cancer
Language English
License http://www.springer.com/tdm
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c652t-f901ec7250c3b468b75f74bafc9511a9abe409f59ad6c38632abba00e067b7223
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
PMID 21935600
PQID 913319550
PQPubID 36266
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3272362
proquest_miscellaneous_913722299
proquest_miscellaneous_1458527786
proquest_journals_913319550
gale_infotracmisc_A356581060
gale_infotracacademiconefile_A356581060
gale_healthsolutions_A356581060
pubmed_primary_21935600
pascalfrancis_primary_25422632
crossref_primary_10_1007_s10549_011_1770_1
crossref_citationtrail_10_1007_s10549_011_1770_1
springer_journals_10_1007_s10549_011_1770_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-01-01
PublicationDateYYYYMMDD 2012-01-01
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Boston
PublicationPlace_xml – name: Boston
– name: Dordrecht
– name: Netherlands
PublicationTitle Breast cancer research and treatment
PublicationTitleAbbrev Breast Cancer Res Treat
PublicationTitleAlternate Breast Cancer Res Treat
PublicationYear 2012
Publisher Springer US
Springer
Springer Nature B.V
Publisher_xml – name: Springer US
– name: Springer
– name: Springer Nature B.V
References Holmes (CR11) 2005; 293
Irwin, McTiernan, Manson, Thomson, Sternfeld, Stefanick, Wactawski-Wende, Craft, Lane, Martin, Chlebowski (CR23) 2011; 4
CR19
Johnson-Kozlow, Rock, Gilpin, Hollenbach, Pierce (CR14) 2007; 31
Bertram, Stefanick, Saquib, Natarajan, Patterson, Bardwell, Flatt, Newman, Rock, Thomson, Pierce (CR28) 2011; 22
Cheifetz, Moore, Brooks, Barbaric (CR4) 2010; 62
Borugian, Sheps, Kim-Sing, Van Patten, Potter, Dunn, Gallagher, Hislop (CR20) 2004; 13
Pierce, Stefanick, Flatt, Natarajan, Sternfeld, Madlensky, Al-Delaimy, Thomson, Kealey, Hajek, Parker, Newman, Caan, Rock (CR21) 2007; 25
Staten, Taren, Howell, Tobar, Poehlman, Hill, Reid, Ritenbaugh (CR10) 2001; 33
Friedenreich, Gregory, Kopciuk, Mackey, Courneya (CR22) 2009; 124
Ainsworth, Haskell, Leon, Jacobs, Montoye, Sallis, Paffenbarger (CR15) 1993; 25
Shu, Zheng, Cai, Gu, Chen, Zheng, Lu (CR9) 2009; 302
Holick, Newcomb, Trentham-Dietz, Titus-Ernstoff, Bersch, Stampfer, Baron, Egan, Willett (CR27) 2008; 17
Caan, Sternfeld, Gunderson, Coates, Quesenberry, Slattery (CR6) 2005; 16
CR2
CR3
Matthews, Shu, Yang, Jin, Ainsworth, Liu, Gao, Zheng (CR13) 2003; 158
Smith-Warner (CR16) 2006; 163
Colditz, Hankinson (CR8) 2005; 5
DerSimonian, Laird (CR17) 1986; 7
Schmitz, Courneya, Matthews, Demark-Wahnefried, Galvao, Pinto, Irwin, Wolin, Segal, Lucia, Schneider, von Gruenigen, Schwartz (CR25) 2010; 42
Nechuta, Caan, Chen, Flatt, Lu, Patterson, Poole, Kwan, Chen, Weltzien, Pierce, Shu (CR5) 2011; 22
Pierce, Faerber, Wright, Rock, Newman, Flatt, Kealey, Jones, Caan, Gold, Haan, Hollenbach, Jones, Marshall, Ritenbaugh, Stefanick, Thomson, Wasserman, Natarajan, Thomas, Gilpin (CR7) 2002; 23
(CR1) 2008; 67
Patterson, Cadmus, Emond, Pierce (CR18) 2010; 66
Wolf, Hunter, Colditz, Manson, Stampfer, Corsano, Rosner, Kriska, Willett (CR12) 1994; 23
McTiernan, Irwin, VonGruenigen (CR24) 2010; 28
Sternfeld, Weltzien, Quesenberry, Castillo, Kwan, Slattery, Caan (CR26) 2009; 18
ML Irwin (1770_CR23) 2011; 4
JP Pierce (1770_CR21) 2007; 25
BE Ainsworth (1770_CR15) 1993; 25
RE Patterson (1770_CR18) 2010; 66
CE Matthews (1770_CR13) 2003; 158
R DerSimonian (1770_CR17) 1986; 7
1770_CR2
B Sternfeld (1770_CR26) 2009; 18
1770_CR1
1770_CR3
LA Bertram (1770_CR28) 2011; 22
CN Holick (1770_CR27) 2008; 17
AM Wolf (1770_CR12) 1994; 23
1770_CR19
SA Smith-Warner (1770_CR16) 2006; 163
LK Staten (1770_CR10) 2001; 33
JP Pierce (1770_CR7) 2002; 23
O Cheifetz (1770_CR4) 2010; 62
SJ Nechuta (1770_CR5) 2011; 22
MJ Borugian (1770_CR20) 2004; 13
B Caan (1770_CR6) 2005; 16
MD Holmes (1770_CR11) 2005; 293
CM Friedenreich (1770_CR22) 2009; 124
M Johnson-Kozlow (1770_CR14) 2007; 31
GA Colditz (1770_CR8) 2005; 5
A McTiernan (1770_CR24) 2010; 28
XO Shu (1770_CR9) 2009; 302
KH Schmitz (1770_CR25) 2010; 42
References_xml – volume: 13
  start-page: 1163
  issue: 7
  year: 2004
  end-page: 1172
  ident: CR20
  article-title: Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?
  publication-title: Cancer Epidemiol Biomarkers Prev
– volume: 22
  start-page: 427
  issue: 3
  year: 2011
  end-page: 435
  ident: CR28
  article-title: Physical activity, additional breast cancer events, and mortality among early-stage breast cancer survivors: findings from the WHEL study
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-010-9714-3
– volume: 23
  start-page: 991
  issue: 5
  year: 1994
  end-page: 999
  ident: CR12
  article-title: Reproducibility and validity of a self-administered physical activity questionnaire
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/23.5.991
– ident: CR2
– volume: 67
  start-page: 114
  issue: 2
  year: 2008
  end-page: 120
  ident: CR1
  article-title: To the Secretary of Health and Human Services. Part A: executive summary
  publication-title: Nutr Rev
– volume: 18
  start-page: 87
  issue: 1
  year: 2009
  end-page: 95
  ident: CR26
  article-title: Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-08-0595
– volume: 163
  start-page: 1053
  issue: 11
  year: 2006
  end-page: 1064
  ident: CR16
  article-title: Methods for pooling results of epidemiologic studies: the pooling project of prospective studies of diet and cancer
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwj127
– volume: 25
  start-page: 2345
  issue: 17
  year: 2007
  end-page: 2351
  ident: CR21
  article-title: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.08.6819
– volume: 22
  start-page: 1319
  issue: 9
  year: 2011
  end-page: 1331
  ident: CR5
  article-title: The after breast cancer pooling project: rationale, methodology, and breast cancer survivor characteristics
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-011-9805-9
– volume: 23
  start-page: 728
  issue: 6
  year: 2002
  end-page: 756
  ident: CR7
  article-title: A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women’s healthy eating and living (WHEL) study
  publication-title: Control Clin Trials
  doi: 10.1016/S0197-2456(02)00241-6
– volume: 124
  start-page: 1954
  issue: 8
  year: 2009
  end-page: 1962
  ident: CR22
  article-title: Prospective cohort study of lifetime physical activity and breast cancer survival
  publication-title: Int J Cancer
  doi: 10.1002/ijc.24155
– volume: 293
  start-page: 2479
  issue: 20
  year: 2005
  end-page: 2486
  ident: CR11
  article-title: Physical activity and survival after breast cancer diagnosis
  publication-title: JAMA
  doi: 10.1001/jama.293.20.2479
– volume: 31
  start-page: 193
  issue: 2
  year: 2007
  end-page: 202
  ident: CR14
  article-title: Validation of the WHI brief physical activity questionnaire among women diagnosed with breast cancer
  publication-title: Am J Health Behav
– ident: CR19
– volume: 302
  start-page: 2437
  issue: 22
  year: 2009
  end-page: 2443
  ident: CR9
  article-title: Soy food intake and breast cancer survival
  publication-title: JAMA
  doi: 10.1001/jama.2009.1783
– ident: CR3
– volume: 62
  start-page: 25
  issue: 1
  year: 2010
  end-page: 34
  ident: CR4
  article-title: Effects of physical activity on cancer survival: a systematic review
  publication-title: Physiotherapy Canada
  doi: 10.3138/physio.62.1.25
– volume: 7
  start-page: 177
  issue: 3
  year: 1986
  end-page: 188
  ident: CR17
  article-title: Meta-analysis in clinical trials
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(86)90046-2
– volume: 33
  start-page: 1959
  issue: 11
  year: 2001
  end-page: 1967
  ident: CR10
  article-title: Validation of the Arizona activity frequency questionnaire using doubly labeled water
  publication-title: Med Sci Sports Exerc
  doi: 10.1097/00005768-200111000-00024
– volume: 25
  start-page: 71
  issue: 1
  year: 1993
  end-page: 80
  ident: CR15
  article-title: Compendium of physical activities: classification of energy costs of human physical activities
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/00005768-199301000-00011
– volume: 28
  start-page: 4074
  issue: 26
  year: 2010
  end-page: 4080
  ident: CR24
  article-title: Weight, physical activity, diet, and prognosis in breast and gynecologic cancers
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.27.9752
– volume: 16
  start-page: 545
  issue: 5
  year: 2005
  end-page: 556
  ident: CR6
  article-title: Life after cancer epidemiology (LACE) study: a cohort of early stage breast cancer survivors (United States)
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-004-8340-3
– volume: 66
  start-page: 5
  issue: 1
  year: 2010
  end-page: 15
  ident: CR18
  article-title: Physical activity, diet, adiposity and female breast cancer prognosis: a review of the epidemiologic literature
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2010.01.004
– volume: 17
  start-page: 379
  issue: 2
  year: 2008
  end-page: 386
  ident: CR27
  article-title: Physical activity and survival after diagnosis of invasive breast cancer
  publication-title: Cancer Epidemiol Biomarker Prev
  doi: 10.1158/1055-9965.EPI-07-0771
– volume: 5
  start-page: 388
  issue: 5
  year: 2005
  end-page: 396
  ident: CR8
  article-title: The nurses’ health study: lifestyle and health among women
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1608
– volume: 42
  start-page: 1409
  issue: 7
  year: 2010
  end-page: 1426
  ident: CR25
  article-title: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/MSS.0b013e3181e0c112
– volume: 158
  start-page: 1114
  issue: 11
  year: 2003
  end-page: 1122
  ident: CR13
  article-title: Reproducibility and validity of the Shanghai women’s health study physical activity questionnaire
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwg255
– volume: 4
  start-page: 522
  issue: 4
  year: 2011
  end-page: 529
  ident: CR23
  article-title: Physical activity and survival in postmenopausal women with breast cancer: results from the women’s health initiative
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.CAPR-10-0295
– volume: 16
  start-page: 545
  issue: 5
  year: 2005
  ident: 1770_CR6
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-004-8340-3
– ident: 1770_CR2
– volume: 163
  start-page: 1053
  issue: 11
  year: 2006
  ident: 1770_CR16
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwj127
– volume: 22
  start-page: 1319
  issue: 9
  year: 2011
  ident: 1770_CR5
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-011-9805-9
– volume: 4
  start-page: 522
  issue: 4
  year: 2011
  ident: 1770_CR23
  publication-title: Cancer Prev Res (Phila)
  doi: 10.1158/1940-6207.CAPR-10-0295
– volume: 17
  start-page: 379
  issue: 2
  year: 2008
  ident: 1770_CR27
  publication-title: Cancer Epidemiol Biomarker Prev
  doi: 10.1158/1055-9965.EPI-07-0771
– volume: 31
  start-page: 193
  issue: 2
  year: 2007
  ident: 1770_CR14
  publication-title: Am J Health Behav
  doi: 10.5993/AJHB.31.2.8
– volume: 25
  start-page: 71
  issue: 1
  year: 1993
  ident: 1770_CR15
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/00005768-199301000-00011
– volume: 62
  start-page: 25
  issue: 1
  year: 2010
  ident: 1770_CR4
  publication-title: Physiotherapy Canada
  doi: 10.3138/physio.62.1.25
– volume: 28
  start-page: 4074
  issue: 26
  year: 2010
  ident: 1770_CR24
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2010.27.9752
– volume: 33
  start-page: 1959
  issue: 11
  year: 2001
  ident: 1770_CR10
  publication-title: Med Sci Sports Exerc
  doi: 10.1097/00005768-200111000-00024
– volume: 66
  start-page: 5
  issue: 1
  year: 2010
  ident: 1770_CR18
  publication-title: Maturitas
  doi: 10.1016/j.maturitas.2010.01.004
– volume: 124
  start-page: 1954
  issue: 8
  year: 2009
  ident: 1770_CR22
  publication-title: Int J Cancer
  doi: 10.1002/ijc.24155
– volume: 293
  start-page: 2479
  issue: 20
  year: 2005
  ident: 1770_CR11
  publication-title: JAMA
  doi: 10.1001/jama.293.20.2479
– ident: 1770_CR1
  doi: 10.1111/j.1753-4887.2008.00136.x
– volume: 25
  start-page: 2345
  issue: 17
  year: 2007
  ident: 1770_CR21
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.08.6819
– volume: 22
  start-page: 427
  issue: 3
  year: 2011
  ident: 1770_CR28
  publication-title: Cancer Causes Control
  doi: 10.1007/s10552-010-9714-3
– volume: 5
  start-page: 388
  issue: 5
  year: 2005
  ident: 1770_CR8
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1608
– volume: 23
  start-page: 728
  issue: 6
  year: 2002
  ident: 1770_CR7
  publication-title: Control Clin Trials
  doi: 10.1016/S0197-2456(02)00241-6
– volume: 23
  start-page: 991
  issue: 5
  year: 1994
  ident: 1770_CR12
  publication-title: Int J Epidemiol
  doi: 10.1093/ije/23.5.991
– volume: 42
  start-page: 1409
  issue: 7
  year: 2010
  ident: 1770_CR25
  publication-title: Med Sci Sports Exerc
  doi: 10.1249/MSS.0b013e3181e0c112
– ident: 1770_CR3
– volume: 18
  start-page: 87
  issue: 1
  year: 2009
  ident: 1770_CR26
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.EPI-08-0595
– volume: 7
  start-page: 177
  issue: 3
  year: 1986
  ident: 1770_CR17
  publication-title: Control Clin Trials
  doi: 10.1016/0197-2456(86)90046-2
– volume: 13
  start-page: 1163
  issue: 7
  year: 2004
  ident: 1770_CR20
  publication-title: Cancer Epidemiol Biomarkers Prev
  doi: 10.1158/1055-9965.1163.13.7
– volume: 158
  start-page: 1114
  issue: 11
  year: 2003
  ident: 1770_CR13
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwg255
– ident: 1770_CR19
  doi: 10.1007/s12032-010-9536-x
– volume: 302
  start-page: 2437
  issue: 22
  year: 2009
  ident: 1770_CR9
  publication-title: JAMA
  doi: 10.1001/jama.2009.1783
SSID ssj0009709
Score 2.4192836
Snippet The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to...
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 h (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs) to...
The 2008 Physical Activity (PA) Guidelines recommend engaging in at least 2.5 hours (10 MET-hours/week) of moderate intensity PA per week (defined as 4 METs)...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 637
SubjectTerms Adult
Aged
Biological and medical sciences
Breast cancer
Breast Neoplasms - epidemiology
Breast Neoplasms - mortality
Breast Neoplasms - rehabilitation
Cancer research
Cancer therapies
Epidemiology
Exercise
Female
Guideline Adherence
Guidelines
Gynecology. Andrology. Obstetrics
Health aspects
Humans
Mammary gland diseases
Medical sciences
Medicine
Medicine & Public Health
Middle Aged
Mortality
Motor Activity
Oncology
Patient Compliance
Physical fitness
Recurrence
Risk Factors
Surveys
Surveys and Questionnaires
Toy industry
Tumors
SummonAdditionalLinks – databaseName: SpringerLINK - Czech Republic Consortium
  dbid: AGYKE
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9UwFD_IBiKI83vdlxEEQelIv5LWt8vYHMp82mA-lSQ3meLoLmvrg0_-6Z7Tpr123gl7zmmSpicnv9Oc8zsAbzSPdBpFOoyEnoeptjzUQqmQzx1qlJIE4ina4os4Pks_nWfnPo-7HqLdhyvJzlL_leyGvkzYhWBJyUN0edYz9E9wN67PPn79fLjk2pV9ZAdReouci-Eyc1Unk-PIG-WHC1XjArm-ssUq6PlvBOWNa9TudDragNPhvfqglB_7baP3za8blI93fPHH8MijVTbr1esJ3LPVU7h_4u_jn8HvE9ulTDOEkWzhPzmjXAkqScEuWiLRosB6pqo5q1u0Sz9JgAqTM03x8A0zpHfXH1h3e15d1IwyXroOV4gxKglGA_o_SM_h7Ojw9OA49DUdQiOyuAkd4g9rJAIvk-hU5FpmTqZaOYNQL1KF0hY9TpcVai5MkoskVlorzi2eqloilnkBa9VVZTeBuTTKXZpnaZIgqEtjzZ02hVSxTTKXZ0UAfPi0pfGE51R347JcUjXTypa4siWtbBkF8G58ZNGzffxP-BXpS9knrI6WopwlCJJzdLV5AG87CbIVOLJRPuUB50-sWxPJnYkk7nEzad6b6OQ4OXTvY2LcD2B7UNLSG6G6LKIEDSy6oAG8HlupZ4qrq-xVW6Pjh-5iTByCAbBbZLAbSVXfcUFf9lq_HB7hP0HmAORkP4wCRF4-bam-f-tIzJNYxgieAng_KP1y4rcu-dadpLfhAcLbuP9htgNrzXVrdxFCNnrPm4w_FZ9nUA
  priority: 102
  providerName: Springer Nature
Title Meeting the physical activity guidelines and survival after breast cancer: findings from the after breast cancer pooling project
URI https://link.springer.com/article/10.1007/s10549-011-1770-1
https://www.ncbi.nlm.nih.gov/pubmed/21935600
https://www.proquest.com/docview/913319550
https://www.proquest.com/docview/1458527786
https://www.proquest.com/docview/913722299
https://pubmed.ncbi.nlm.nih.gov/PMC3272362
Volume 131
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTUJIE-J7YaMYCQkJZJE4H054Qe3UMoFWIUSl8hTZjjOQUFqWlmf-dO4SJ1Vg21MefLVd39n-ne8L4KX2Ax0FgeZBogseaetznSjF_aJEiVKSQDx5W8yTs0X0cRkvnW9O7dwquzOxOaiLlaE38rcZKlNBhnj6_foXp6JRZFx1FTT24IBCQEn3Sk93Hh6ZbD08KLV3kvpJZ9RsI-dQMeKNP5eUPg8G15I7nA_XqsaFKtsKF1dB0P89Kf8xpza31Owe3HXwko1bebgPt2z1AG6fOwP6Q_hzbpsYZ4a4j60djxgFN1ANCXaxpaxX5AnPVFWweosHyW8ioEriTJMD-4YZEpTLd6wxd1cXNaMQlabDK8gY1fCiAd2TzyNYzKZfT8-4K8LATRKLDS8RMFgjESmZUEdJqmVcykir0iA2C1SmtEUVsYwzVSQmTJNQKK2V71u8BrVE8PEY9qtVZY-AlVGQllEaR2GIKCwS2i-1yaQSNozLNM488Dse5MZlKKdCGT_zXW5lYluObMuJbXngwev-J-s2PcdNxM-JsXkbYdpv7XwcIqpNUTf2PXjVUNDmxpGNcjEKOH9KkzWgPBlQ4qY0g-bRQHj6yaE-LihFvgfHnTTl7tSo817GPXjRt1LP5AhX2dW2Rk0N9TtBSf88YNfQYDeSyrTjgj5pxXM3POJ1wrgeyIHg9gSUbXzYUv343mQdD4UUiHY8eNOJ-G7i1y750xv_5jHcQfwp2hetE9jfXG7tM8R4Gz2CPbmUo2Y_j-BgPJtM5vT98O3TFL-T6fzzF2xdiPFfjodT7g
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEB7KFVQQqe-xtV1BEZRgsnnZRChSteVqe4dIC_2W7m42VZDc2dwp_dY_1v_mTLLJEW37rZ8zt7uXmcw-szvzDMBL5fkq9H3l-rHK3VAZz1WxlK6XF2hRUhCIp2yLcTw8DL8cRUdLcNHWwlBaZesTa0edTzSdkb9LMZjyU8TTH6a_XGoaRZerbQcNaTsr5Js1w5it69gzZ38wgqs2dz-jul9xvrN98Gno2iYDro4jPnML3BCNFogEdKDCOFEiKkSoZKERe_gylcpgCFREqcxjHSRxwKVS0vMMunklOPEe4A6wHNL5yQCWP26Pv35bsP6KJseEyMXjxIvba9Wmdg9DM7fOKBPCc_3exmi3h7tTWaGqiqbHxmUg-P9czn8udOt9cmcF7lmAy7Yai7wPS6Z8ALdG9gr_IZyPTF1lzRB5sqm1EkblFdTFgp3MiXeLcvGZLHNWzdGV_SYB6mXOFKXQz5gmUz19z-oL9_KkYlQkUw94iRijLmI0oT10egSHN6KhxzAoJ6V5CqwI_aQIkygMAsSBIVdeoXQqJDdBVCRR6oDX6iDTliOdWnX8zBbszqS2DNWWkdoy34E33U-mDUHIdcIbpNisqXHtnEu2FSCuTjA69xx4XUuQe8GZtbRVErh-IurqSa71JNEt6N7j9Z7xdIvjERVPB9yB1daaMuu3qqz7yhx40T2lkSkVrzSTeYWxIkaYnGgHHWBXyOAwghrF4wt90pjnYnqMGAhlOyB6htsJEN95_0n543vNex5wwRFvOfC2NfHFwq985c-u_ZsbcHt4MNrP9nfHe6twB9Ewb87X1mAwO52b54g4Z2rdftcMjm_alfwFJlaRKw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9RAEB5KC0UQ8d3Y2q6gCEow2bxsIhSptkdr7VHEQr-lu5vdKkjubO4Uv_n3_FfOJJsc0bbf-jlzu3uZyewzuzPPADxTQajiMFR-mKrSj5UJfJVK6QelRYuSgkA8ZVuM073j-MNJcrIEf7paGEqr7Hxi46jLiaYz8tc5BlNhTqTa1mVFHO2M3k6_-9RAii5au24a0nVZKLcatjFX43Fgfv3EaK7e2t9B1T_nfLT7-f2e7xoO-DpN-My3uDkaLRAV6EjFaaZEYkWspNWIQ0KZS2UwHLJJLstUR1kacamUDAKDLl8JThwIuBusCNz0MQ5cebc7Pvq0YAAWbb4JEY2nWZB2V6xtHR-GaX6TXSZE4IeDTdJtFTenska12bbfxkWA-P-8zn8ud5s9c3Qbbjmwy7Zb67wDS6a6C6uH7jr_Hvw-NE3FNUMUyqbOYhiVWlBHC3Y2Jw4uystnsipZPUe39oMEqK85U5ROP2OazPb8DWsu36uzmlHBTDPgBWKMOorRhO4A6j4cX4uGHsByNanMI2A2DjMbZ0kcRYgJY64Cq3QuJDdRYrMk9yDodFBox5dObTu-FQumZ1JbgWorSG1F6MHL_ifTlizkKuFNUmzR1rv2jqbYjhBjZxipBx68aCTI1eDMWrqKCVw_kXYNJNcHkugi9ODxxsB4-sXxhAqpI-7BWmdNhfNhddF_cR487Z_SyJSWV5nJvMa4EaNNThSEHrBLZHAYQU3j8YU-bM1zMT1GD4S4PRADw-0FiPt8-KT6-qXhQI-44Ii9PHjVmfhi4Ze-8sdX_s1NWEWXUnzcHx-swQ0Exrw9aluH5dn53DxB8DlTG-6zZnB63Z7kL2ZSlW8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Meeting+the+physical+activity+guidelines+and+survival+after+breast+cancer%3A+findings+from+the+after+breast+cancer+pooling+project&rft.jtitle=Breast+cancer+research+and+treatment&rft.au=Beasley%2C+Jeannette+M&rft.au=Kwan%2C+Marilyn+L&rft.au=Chen%2C+Wendy+Y&rft.au=Weltzien%2C+Erin+K&rft.date=2012-01-01&rft.pub=Springer&rft.issn=0167-6806&rft.volume=131&rft.issue=2&rft.spage=637&rft_id=info:doi/10.1007%2Fs10549-011-1770-1&rft.externalDocID=A356581060
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6806&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6806&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6806&client=summon